UPLIZNA Offers gMG Patients Deep and Durable Symptom Control and Twice-Yearly Dosing*First and Only CD19-Targeted B Cell Therapy Approved in anti-AChR and ...
Establishments using a U.S.-origin claim on FSIS-regulated products will need to provide access to documentation ...
Amid concerns over an imported spice with expiration dates stretching well into the future, here's what officials want you to know.
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
A recent preemption decision out of the Southern District of New York offers encouraging news for medical device ...
Establishments using US-origin claims will need to demonstrate the product meets regulatory requirements, effective Jan. 1.
The narrow FDA labeling makes it so that only a minority of men who could benefit from treatment are considered ‘on-label’ ...
FDA's new guidance clarifies promotional practices for biosimilars, ensuring accurate marketing and preventing misleading ...
Treatment with neflamapimod slowed clinical worsening and led to reduced disease-related plasma biomarkers in individuals with dementia with Lewy bodies, according to a speaker at CTAD. “Dementia with ...
“FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” ...
The cookies were sold between November 15 and December 9 at all Lunds & Byerlys stores in the Twin Cities and St. Cloud ...
" It sounds wholesome, right? Pure. Like something your grandmother might have used in her kitchen. The clean label movement has exploded in recent years, with half of industry professionals ...